Smoking, organic solvents, and genetic susceptibility combine to increase MS risk.
A recent study has suggested that a substance called Hm-3, which is derived from crab spider toxin, may pave the way for new treatments for a subtype of the rare neuromuscular disorder, primary periodic paralysis.
A new drug called BAN2401 has shown promise in decreasing amyloid in early AD, according to results from a phase II study.
Is there a correlation between sickle cell trait and incidence of ischemic stroke among African-Americans?
A 39-year-old male with a past medical history of hypertension and depression woke up with a severe headache, difficulty speaking, and right-sided weakness. Read the case details here.
Researchers sought to find whether the risk of later cerebrovascular events was associated with a hospital admission for migraine.
A 36-year-old male presents with new-onset tremors of the hands. He is a project manager at a small company, and he is increasingly self-conscious about his condition that is getting worse at his high-stress job.
This just in: the first study to systematically evaluate cluster headache in individuals never exposed to tobacco smoke versus those who have been exposed.
A small but noteworthy study examined whether DBS could improve motor symptoms in early PD.
Few prospective studies have been conducted to guide treatment decisions for this rare disorder. Now, a recent review describes the characteristics, diagnosis, and treatment of the group of neuromuscular disorder subtypes known as PPP.
PPP is a disabling and chronic condition marked by symptoms, such as anxiety, muscle weakness, pain, fatigue, and temporary paralysis.
What are the main types of ketogenic diets and what advantages do they hold for epilepsy management? Take the quiz and learn more.
A 20-year-old female presents with headache symptoms that, upon fundoscopic examination, potentially point to a medical emergency.
Conscious sedation or local anesthesia? That is the question. Dr. Lazzara reports for Neurology Times.
A new study has found that an RNA-binding protein called TDP-43 could be a promising new biomarker for diagnosing amyotropic lateral sclerosis.